Cyfuse Biomedical KK (TSE:4892) Change In Inventory: 円0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4892 Cyfuse Biomedical KK TSE:4892
55 GF Score
Price 円557.00
GF Value 円2,207.29
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Cyfuse Biomedical KK Change In Inventory?

Cyfuse Biomedical KK TSE:4892 -1.42% 55 Change In Inventory is 円0.0 Mil as of Jun. 2026. GuruFocus rates TSE:4892 with a GF Score™ of 55/100 and a GF Value™ of 円2,207.29 (Possible Value Trap). The stock has 5 warning signs investors should review.

Cyfuse Biomedical KK's change in inventory for the quarter that ended in Jun. 2026 was 円0.0 Mil. It means Cyfuse Biomedical KK's inventory stayed the same from Mar. 2026 to Jun. 2026 .

Cyfuse Biomedical KK's change in inventory for the fiscal year that ended in Dec. 2025 was 円-33.2 Mil. It means Cyfuse Biomedical KK's inventory increased by 円33.2 Mil from Dec. 2024 to Dec. 2025 .

Cyfuse Biomedical KK's Total Inventories for the quarter that ended in Jun. 2026 was 円73.8 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. Cyfuse Biomedical KK's Inventory Turnover for the quarter that ended in Jun. 2026 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cyfuse Biomedical KK  (TSE:4892) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cyfuse Biomedical KK's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=82.8185/0*365 / 4
=N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cyfuse Biomedical KK's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0 / 82.8185
=0.00

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cyfuse Biomedical KK's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=82.8185 / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyfuse Biomedical KK Change In Inventory Related Terms

Cyfuse Biomedical KK Change In Inventory Historical Data

* Premium members only.

The historical data trend for Cyfuse Biomedical KK's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyfuse Biomedical KK Change In Inventory Chart

Cyfuse Biomedical KK Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial -38.53 21.37 -5.65 -9.54 -33.15

Cyfuse Biomedical KK Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4892
55GF Score
Cyfuse Biomedical KK TSE:4892
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cyfuse Biomedical KK Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of 円0.0 Mil mean?
Cyfuse Biomedical KK (TSE:4892) has a Change In Inventory of 円0.0 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Cyfuse Biomedical KK and its competitors.
Is Cyfuse Biomedical KK's Change In Inventory too high?
Cyfuse Biomedical KK's current Change In Inventory is 円0.0 Mil. Overall, Cyfuse Biomedical KK has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cyfuse Biomedical KK's Change In Inventory compare to ZTS?
Cyfuse Biomedical KK's Change In Inventory of 円0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Cyfuse Biomedical KK and its competitors. Cyfuse Biomedical KK's current Change In Inventory is 円0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyfuse Biomedical KK stock overvalued right now?
Based on GuruFocus' analysis, Cyfuse Biomedical KK (TSE:4892) is currently considered Possible Value Trap. The stock's GF Value™ is 円2,207.29, compared to a current price of 円557.00 — trading 74.8% below its estimated fair value. The current Change In Inventory is 円0.0 Mil. Cyfuse Biomedical KK's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Cyfuse Biomedical KK (TSE:4892), the current Change In Inventory is 円0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cyfuse Biomedical KK (TSE:4892) Overvalued in 2026?

Based on GuruFocus' analysis, Cyfuse Biomedical KK stock appears to be undervalued. The current stock price of 円557.00 is trading 74.8% below its estimated GF Value™ of 円2,207.29. GuruFocus considers Cyfuse Biomedical KK to be Possible Value Trap.

Key valuation signals for TSE:4892:

  • Change In Inventory: 円0.0 Mil
  • GF Value™: 円2,207.29 vs. price of 円557.00 (74.8% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the TSE:4892 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cyfuse Biomedical KK Business Description

Other Exchanges 4892:Japan
Address 3-5-27 Mita, 1st Floor, Sumitomo Real Estate Tokyo Mita South Tower, Minato-ku, Tokyo, JPN, 108-6301
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine-related products. The company focuses on delivering three-dimensional tissues and organs created solely from cells as new 3D cell products to medical fields, including regenerative medicine and drug discovery, through the practical application of three-dimensional cell stacking technology. It is engaged in multifaceted development in the following areas: regenerative medicine, drug discovery support, and the device domain, including the development and sales of 3D cell stacking system equipment, such as bio 3D printers equipped with the company's platform technology.
55GF Score

Get the complete analysis for TSE:4892

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円557.00
Price
円2,207.29
GF Value